Neurointerventional Devices Market sales revenue expected to register 4.7% CAGR by 2030

The global neurointerventional devices market is predicted to develop at a CAGR of 4.7% from 2022 to 2030, with a market value of roughly US$ 2.5 billion in 2022. According to Future Market Insights, hospitals will account for more than 90.4% of the global market by end user in 2021. According to the study, the market will reach US$ 3.6 Billion in revenues by the end of 2030.

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

Request a Report Sample to Gain Comprehensive Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-871

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 3.6 Billion is predicted for the market.

Global Neurointerventional Devices Market- Key Takeaways

  • North America shall be the market hegemon, holding a 40.7% market share from 2020 to 2030
  • Embolic coils to capture the majority share, carotid stents to surge in popularity
  • High incidence of cerebral aneurysm to accelerate adoption of coiling procedures
  • Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-871

Competitive Intelligence
Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

More Insights Available:

The North American region is expected to dominate the neurosurgery devices market during the forecast period. The presence of a well-established healthcare infrastructure and the increasing prevalence of neurological disorders are driving the growth of the market in this region. The United States is the largest market for neurosurgery devices in North America due to the high adoption rate of technologically advanced products.

Buy Now@ https://www.futuremarketinsights.com/checkout/871

Key Market Segments Covered In Neurointerventional Devices Industry Research

By Product:

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Neurovascular Thrombectomy
  • Embolic Protection Devices
  • Flow Diverters Devices
  • Intrasaccular Devices
  • Liquid Embolic
  • Balloons
  • Stent Retrievers

By Technique:

  • Neurothrombectomy Procedure
  • Cerebral Angiography
  • Stenting
  • Coiling Procedures
  • Flow Disruption

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these